Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook

Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook

MELVILLE, N.Y., May 1 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. NASDAQ: GTIV, the nation's leading provider of comprehensive home health services, today reported the following financial results for the first quarter ended March 30, 2008:

    (Logo:  http://www.newscom.com/cgi-bin/prnh/20060323/NYTH117LOGO)

    -- Net revenues increased 8% to $323.7 million versus the first quarter
       ended April 1, 2007.
    -- Net income increased 13% to $7.7 million, or $0.27 per diluted share,
       versus $6.8 million, or $0.24 per diluted share, for the prior year
       period. Average diluted shares were 29.0 million versus 28.4 million in
       the 2007 first quarter.
    -- Earnings before interest, taxes, depreciation and amortization (EBITDA)
       increased 3% to $23.8 million in the first quarter of 2008. EBITDA as a
       percentage of net revenues was 7.4% in the 2008 first quarter versus
       7.7% in the prior year period.
    -- EBITDA included restructuring and integration costs of $0.3 million for
       the first quarter of 2008 as compared to $1.0 million for the prior
       year period.

"Gentiva's first quarter was an important transitional period as we adapted to new Medicare Prospective Payment System (PPS) rules, integrated our recent Mississippi acquisition and implemented contract renewals within CareCentrix," said Gentiva Chairman and CEO Ron Malone. "While we were pleased with our revenue growth, some of the quarter's events had a short-term, moderating effect on profitability. However, we are able to reaffirm our financial outlook for the full year, based on our review of current business trends, our progress in adapting to the changed Medicare environment, and our commercial business opportunities. We expect 2008 to be another good year for Gentiva."

The Company noted the following first quarter performance highlights in its Home Health segment:

    -- Home Health revenues were up 6% to $217.0 million versus the prior year
       period, driven primarily by continuing growth from the Company's
       expanding specialty programs, an increase in revenues from the
       segment's commercial business as a result of the Company's ongoing
       pricing strategy, and the inclusion of about $3 million in net revenues
       from Home Health Care Affiliates, Inc., in Mississippi, which was
       acquired by Gentiva on February 29, 2008.
    -- Home Health operating contribution rose 4% to $31.2 million, with the
       operating contribution margin at 14.4% in the first quarter of 2008
       versus 14.6% in the prior year period.  While the segment's operating
       contribution has continued to benefit from the change in revenue mix to
       higher-margin payers, results were affected by costs related primarily
       to Gentiva's adoption of new PPS rules and recruitment initiatives to
       grow capacity and productivity.
    -- Revenues for Gentiva's Medicare PPS home health business increased more
       than 7% versus the prior year period.  Patient admissions remained
       strong, although the current impact of new PPS rules contributed to a
       revenue growth rate below those of recent quarters.  Medicare Advantage
       revenues in Home Health -- under which Gentiva is paid for patient
       episodes similar to the rate structure and levels of Medicare PPS --
       more than doubled during the first quarter versus the prior year
       period.  As a result, growth in episodic revenues (the combined
       revenues from Medicare PPS and Medicare Advantage business paid on an
       episodic basis) was 11% year-over-year, despite the adverse impact of
       PPS changes.

Gentiva reported the following results in its CareCentrix and Other Related Services segments:

    -- Revenues for CareCentrix rose more than 18% to $77.8 million as this
       segment continued to benefit from its servicing of increased
       managed care membership enrollments and new business.
    -- CareCentrix' operating contribution declined by 9% to $6.3 million due
       primarily to expected short-term increases in utilization under
       capitated agreements, selected pricing changes resulting from a recent
       contract extension with CIGNA HealthCare, and investments in
       CareCentrix' expanded sales force.  The Company anticipates additional
       business opportunities for CareCentrix during the remainder of 2008,
       including the continuing shift of CIGNA's membership from capitated to
       fee-for-service plans, and potential benefits from CIGNA's
       first quarter acquisition of Great-West Healthcare.
    -- Net revenues and operating contribution for the smaller Other Related
       Services segment, which consists of hospice, respiratory and home
       medical equipment, infusion therapy and consulting, were slightly below
       the prior year period as the Company continued to make investments and
       operational changes aimed at improving the segment's financial
       performance.

During the first quarter of 2008, Gentiva used $43 million of cash and incurred an additional $12 million in debt to fund the Home Health Care Affiliates acquisition. Despite the resulting increase in long-term debt to $322 million at March 30, 2008, Gentiva's leverage ratio remains below 3.0 and this has allowed the Company to maintain lower interest margins on its revolving credit and term loan borrowings as compared to the prior year.

Gentiva also reaffirmed its 2008 financial outlook of net revenues in a range of $1.28 billion to $1.32 billion and diluted earnings per share in a range between $1.32 and $1.40.

Non-GAAP Financial Measures

The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those measures to the most directly comparable GAAP measures.

Conference Call and Web Cast Details

The Company will comment further on its first quarter results during its conference call and live web cast to be held Thursday, May 1, 2008, at 10:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call #42736083. The web cast is an audio-only, one-way event. Web cast listeners who wish to ask questions must participate in the conference call. Log onto http://investors.gentiva.com/events.cfm to hear the web cast. This press release is accessible at http://investors.gentiva.com/releases.cfm and a transcript of the conference call is expected to be available on the site within 36 hours after the call.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix(R), which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-E

                          (tables and notes follow)



      (in 000's, except per share data)                   1st Quarter
                                                     2008              2007
    Statements of Income
      Net revenues                                $323,722          $299,542
      Cost of services and goods sold              187,199           170,121
      Gross profit                                 136,523           129,421
      Selling, general and administrative expenses 117,880           111,065
      Operating income                              18,643            18,356
      Interest expense                              (6,093)           (7,139)
      Interest income                                  667               817
      Income before income taxes                    13,217            12,034
      Income tax expense                             5,494             5,195
      Net income                                    $7,723            $6,839

     Earnings per Share
      Net income:
         Basic                                       $0.27             $0.25
         Diluted                                     $0.27             $0.24

      Average shares outstanding:
         Basic                                      28,282            27,530
         Diluted                                    29,043            28,439

    Condensed Balance Sheets
     ASSETS                                     Mar 30, 2008      Dec 30, 2007
      Cash, cash equivalents and
       restricted cash (A)                         $16,382           $36,181
      Short-term investments (B)                     1,350            31,250
      Accounts receivable, net (C)                 230,190           207,801
      Deferred tax assets                           17,551            18,859
      Prepaid expenses and other current assets     16,041            14,415
           Total current assets                    281,514           308,506

      Long-term investments (B)                     12,641               -
      Fixed assets, net                             62,534            59,562
      Intangible assets, net                       233,872           211,602
      Goodwill                                     310,909           276,100
      Other assets                                  25,893            26,463
          Total assets                            $927,363          $882,233

     LIABILITIES AND SHAREHOLDERS' EQUITY
      Current portion of long-term debt             $3,072            $2,304
      Accounts payable                              24,219            20,093
      Payroll and related taxes                     28,057            17,163
      Deferred revenue                              31,790            29,015
      Medicare liabilities                           8,257             7,985
      Cost of claims incurred but not reported      22,732            24,321
      Obligations under insurance programs          36,733            36,816
      Other accrued expenses                        39,616            42,282
           Total current liabilities               194,476           179,979

      Long-term debt                               318,928           307,696
      Deferred tax liabilities, net                 55,218            48,572
      Other liabilities                             21,672            22,557
      Shareholders' equity                         337,069           323,429
           Total liabilities and
            shareholders' equity                  $927,363          $882,233

      Common shares outstanding                     28,402            28,046

    (A) Cash, cash equivalents and restricted cash included restricted cash of
        $0.3 million at March 30, 2008 and $22.0 million at December 30, 2007.
    (B) Short-term and long-term investments at March 30, 2008 and
        December 30, 2007 consisted of AAA-rated auction rate securities.  At
        March 30, 2008, long-term investments were presented net of a
        $0.4 million valuation allowance, the charge for which was recorded in
        Shareholders' Equity.
    (C) Accounts receivable, net, included an allowance for doubtful accounts
        of $9.3 million and $9.4 million at March 30, 2008 and
        December 30, 2007, respectively.



      (in 000's)                                          1st Quarter

    Condensed Statements of Cash Flows                2008              2007
     OPERATING ACTIVITIES:
     Net income                                      $7,723            $6,839
     Adjustments to reconcile net income to
      net cash provided by operating activities:
       Depreciation and amortization                  5,151             4,783
       Amortization of debt issuance costs              287               206
       Provision for doubtful accounts                2,600             1,992
       Equity-based compensation expense              1,734             1,652
       Windfall tax benefits associated
        with equity-based compensation               (1,235)             (241)
       Deferred income taxes                          4,848             3,699
     Changes in assets and liabilities,
      net of acquired business:
       Accounts receivable                          (19,598)          (17,741)
       Prepaid expenses and other current assets     (2,151)           (4,863)
       Current liabilities                            8,825            18,660
      Other, net                                        (49)              695
      Net cash provided by operating activities       8,135            15,681

     INVESTING ACTIVITIES:
     Purchase of fixed assets                        (6,624)           (6,445)
     Acquisition of businesses, net of
      cash acquired                                 (47,405)              -
     Purchases of short-term investments
      available-for-sale                            (28,000)          (17,000)
     Maturities of short-term investments
      available-for-sale                             44,900            12,800
     Net cash used in investing
      activities                                    (37,129)          (10,645)

     FINANCING ACTIVITIES:
     Proceeds from issuance of common stock           4,119             2,188
     Windfall tax benefits associated
      with equity-based compensation                  1,235               241
     Borrowings under revolving credit facility      12,000               -
     Home Health Care Affiliates debt repayments     (7,420)              -
     Debt issuance costs                               (432)              -
     Other debt repayments                              -              (7,000)
     Repayment of capital lease obligations            (307)             (294)
     Net cash provided by (used in)
      financing activities                            9,195            (4,865)

     Net change in cash, cash equivalents
      and restricted cash                           (19,799)              171
     Cash, cash equivalents and restricted cash
      at beginning of period                         36,181            32,910
     Cash, cash equivalents and
      restricted cash at end of period              $16,382           $33,081

     SUPPLEMENTAL DISCLOSURES OF CASH
      FLOW INFORMATION:

     Interest paid                                   $5,702            $7,912
     Income taxes paid, net of refunds                 $416              $286



      (in 000's)
     Supplemental Information                             1st Quarter
                                                     2008              2007
    Segment Information (1)
     Net revenues
      Home Health                                 $217,000          $205,031
      CareCentrix                                   77,848            65,890
      Other Related Services                        29,818            30,563
      Intersegment revenues                           (944)           (1,942)
     Total net revenues                           $323,722          $299,542

     Operating contribution (3)
      Home Health                                  $31,202           $29,988
      CareCentrix                                    6,326             6,954
      Other Related Services                         2,845             3,987
     Total operating contribution                   40,373            40,929
     Corporate expenses                            (16,579)          (17,790)
     Depreciation and amortization                  (5,151)           (4,783)
     Interest expense, net                          (5,426)           (6,322)
     Income before income taxes                    $13,217           $12,034

                                                          1st Quarter
                                                     2008              2007
     Net Revenues by Major Payer Source:
      Medicare
        Home Health                               $145,106          $135,254
        Other                                       14,574            15,289
        Total Medicare                             159,680           150,543
      Medicaid and local government                 35,365            38,327
      Commercial insurance and other (4)           128,677           110,672
           Total net revenues                     $323,722          $299,542

    A reconciliation of EBITDA to Net income
     - As Reported amounts follows: (2)
                                                          1st Quarter
                                                     2008              2007
      EBITDA (3)                                   $23,794           $23,139
      Depreciation and amortization                 (5,151)           (4,783)
      Interest expense, net                         (5,426)           (6,322)
      Income before income taxes                    13,217            12,034
      Income tax expense (5)                        (5,494)           (5,195)
      Net income - As Reported                      $7,723            $6,839



    Notes:
    (1) The Company's senior management evaluates performance and allocates
        resources based on operating contributions of the reportable segments,
        which exclude corporate expenses, depreciation, amortization, and
        interest expense (net), but include revenues and all other costs
        directly attributable to the specific segment.

    (2) EBITDA, a non-GAAP financial measure, is defined as income before
        interest expense (net of interest income), income taxes, depreciation
        and amortization. Management uses EBITDA to evaluate overall
        performance and compare current operating results with other companies
        in the healthcare industry. EBITDA should not be considered in
        isolation or as a substitute for net income, operating income or cash
        flow statement data determined in accordance with accounting
        principles generally accepted in the United States. Because EBITDA is
        not a measure of financial performance under accounting principles
        generally accepted in the United States and is susceptible to varying
        calculations, it may not be comparable to similarly titled measures in
        other companies.

    (3) Operating contribution and EBITDA for the first quarter of 2008
        included restructuring and integration costs of $0.3 million, of which
        $0.1 million is associated with the Home Health segment, and
        $0.2 million is included in corporate expenses. For the first quarter
        of 2007, operating contribution and EBITDA included $0.3 million
        associated with the Home Health segment and $0.7 million associated
        with corporate expenses.

    (4) Commercial insurance and other revenues included revenues from
        Medicare Advantage business paid on an episodic basis of $11.1 million
        for the first quarter of 2008 and $5.4 million for the first quarter
        of 2007.

    (5) The Company's effective tax rate was 41.6% and 43.2% for the first
        quarters of 2008 and 2007, respectively.

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include, among others, the following: economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels, including changes to the Medicare home health Prospective Payment System effective January 1, 2008; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters or terrorist acts; ability to successfully integrate the operations of acquisitions the Company may make and achieve expected synergies and operational efficiencies within expected time-frames; effect on liquidity of the Company's debt service requirements; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 30, 2007.

     Financial and Investor Contact:  John R. Potapchuk
                                      631-501-7035
                                      john.potapchuk@gentiva.com

     Media Contact:                   David Fluhrer
                                      631-501-7102
                                      516-589-0778
                                      david.fluhrer@gentiva.com
Website: http://www.gentiva.com/




Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.



Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved.
A
United Business Media company.